ABSTRACT
BACKGROUND: Obstructive Sleep Apnea (OSA) is a significant health issue due to noncompliance with continuous positive airway pressure treatment. Therefore, evaluating alternative treatments is crucial. PURPOSE: Analyze the impact of maxillomandibular advancement using bilateral internal ramus distraction (BIRD) on quality of life (QOL) in OSA patients. STUDY DESIGN, SETTING, AND SAMPLE: A prospective cohort study was conducted at the Oral and Maxillofacial Surgery Department of the University Hospital "La Princesa." The study included patients with moderate to severe OSA who were treated with the BIRD approach. PREDICTOR VARIABLE: Changes in measured variables were analyzed at three time points: before surgery (T1), after mandibular advancement (T2), and after maxillary advancement (T3). MAIN OUTCOME VARIABLE(S): QOL changes measured by Quebec Sleep Questionnaire and the Epworth Sleepiness Scale. Secondary outcomes included: apnea-hypopnea index (AHI), oxygen desaturation index, and percentage of time with saturation below 90%. COVARIATES: Age, sex, continuous positive airway pressure treatment, cephalometric variables and cardiovascular risk parameters were considered. ANALYSES: Statistical analysis employed the Friedman test and χ2 test, with a significance level of P ≤ .05. RESULTS: The study included 32 patients (22% with moderate OSA, 78% with severe OSA). Epworth Sleepiness Scale scores significantly decreased between T1 (13.4 ± 4.4) and T2 (5.8 ± 3.6) and T3 (1.9 ± 1.8) (P < .001). QOL improvements were observed in all domains: daytime sleepiness T1 (3.0 ± 1.3) T2 (5.4 ± 1.4) T3 (6.3 ± 1.0); diurnal symptoms T1 (2.5 ± 1.4) T2 (5.2 ± 1.3) T3 (6.2 ± 1.1); nocturnal symptoms T1 (2.5 ± 1.1) T2 (5.6 ± 1.1) T3 (6.5 ± 0.8); emotions T1 (2.6 ± 1.6) T2 (5.3 ± 1.4) T3 (6.5 ± 0.9); and social interaction T1 (2.5 ± 1.6) T2 (5.4 ± 1.6) T3 (6.3 ± 1.2) (P < .001). AHI decreased between T1 (47.9 ± 23.1) and T2 (14.4 ± 14.3) and T3 (4.7 ± 5.6) h-1 (P < .001), with a final cure rate of 81.2% (defined as final AHI<5 h-1). Oxygen desaturation index and percentage of time with saturation below 90% also showed significant reductions (P < .001). CONCLUSIONS AND RELEVANCE: BIRD approach for OSA demonstrated a high cure rate and significant QOL improvements. It shows promise as an effective surgical option. Further research and long-term follow-up are needed.
ABSTRACT
Presentamos un nuevo abordaje mínimamente invasivo mediante distracción intraoral de rama mandibular bilateral (bilateral internal ramus distraction) para el tratamiento del síndrome de apnea obstructiva del sueño en el paciente adulto. Tras la planificación virtual 3D, el paciente es intervenido bajo anestesia general y asistencia endoscópica, dentro de un protocolo de cirugía mayor ambulatoria, y es dado de alta el mismo día de la cirugía. Tras un periodo de 5días, la rama mandibular se alarga verticalmente durante un periodo que oscila entre 10 y 50 días, a un ritmo de 0,5 a 1mm diario, hasta que el índice de apnea hipopnea alcanza una cifra inferior a 5 pausas por hora (nivel de curación) o el resalte negativo dentario (overjet) se sitúa en valores que ya superan los 10mm. La titulación del procedimiento mediante parámetros clínicos, poligráficos o polisomnográficos permite al cirujano personalizar el avance mandibular en cada caso. Tras un alargamiento que suele oscilar entre 10 y 25mm, los distractores se mantienen durante 6meses hasta que concluye el periodo de consolidación. La indicación de cirugía maxilar tras el avance mandibular se realizará en dependencia del índice de apnea hipopnea residual, de la oclusión y del análisis facial. La distracción intraoral de rama mandibular bilateral es una técnica altamente efectiva para la curación del síndrome de apnea obstructiva del sueño en pacientes adultos con o sin retrognatia, y podría estar indicada incluso en pacientes con morbilidades asociadas, como enfermedades cardiovasculares graves u obesidad mórbida, en los que un procedimiento quirúrgico de mayor envergadura, como el avance maxilomandibular clásico, se descarta como alternativa quirúrgica
An innovative and minimally invasive approach for adult obstructive sleep apnoea by using bilateral internal ramus distraction osteogenesis of the mandible is presented. After a careful virtual 3D planning, mandibular distraction surgery is performed under general anaesthesia and endoscopic assistance, using a major ambulatory surgery protocol, with the patient being discharged home the same day. After an initial latency of 5days, the ascending ramus is gradually lengthened vertically during a period varying between 10 and 50 days, at a rate of 0.5mm to 1mm daily, until an apnoea-hypopnoea index below 5/h is achieved (cure level), and/or a negative overjet>10mm is reached. Titration of the procedure according to clinical criteria with the assistance of polygraphy and/or polysomnography allows the clinician to customise the mandibular advancement to each particular case. After a mandibular ramus lengthening ranging between 10 and 25mm, the distraction devices are kept in place for 6months after completion of the consolidation period. Bilateral internal ramus distraction is a highly effective surgical technique in curing obstructive sleep apnoea in adults with or without retrognathia, and could be indicated even in patients with comorbidities, such as cardiovascular disease or morbid obesity, in which a major surgical procedure, i.e. conventional maxillomandibular advancement, should be discouraged
Subject(s)
Humans , Female , Middle Aged , Sleep Apnea, Obstructive/surgery , Minimally Invasive Surgical Procedures/methods , Orthognathic Surgery/methods , Osteogenesis, Distraction/methods , Quality of Life , Sleep Apnea Syndromes/surgery , Airway Obstruction/complications , Polysomnography/methods , Surveys and QuestionnairesABSTRACT
PURPOSE: A variety of drugs have been used to activate and identify the epileptogenic area in patients during presurgical evaluation. We have evaluated the safety and usefulness of etomidate in identifying the epileptic zone by measuring bioelectrical brain activity and cerebral blood flow (CBF). METHODS: We studied 13 men and 9 women under presurgical evaluation for temporal lobe epilepsy. We applied etomidate (0.1 mg/kg) while patients were monitored by video-electroencephalography (VEEG) with foramen ovale electrodes. In a subset of 15 patients, we also measured CBF with single photon emission computed tomography (SPECT). RESULTS: (1) Etomidate induced seizures in 2 of 22 patients. (2) The main side-effects observed were myoclonus (14 of 20) and moderate pain (3 of 20). (3) No changes in capillary oxygen saturation, respiration, or heart rate were observed. (4) Irritative activity specifically increased in the temporal mesial and lateral areas. No spikes were observed in other areas, aside from those observed under baseline conditions. (5) Irritative activity induced by etomidate correctly lateralized the ictal onset zone in 19 of 20 patients. In addition, the two etomidate-induced seizures appeared in the same regions as spontaneous ones. (6) The kinetics of pharmacologically induced activity was higher in the region of the ictal-onset zone. (7) Etomidate increased the CBF in the basal ganglia and especially in the posterior hippocampus of the temporal mesial region contralateral to the ictal-onset zone. DISCUSSION: Etomidate activation is a safe, specific, and quick test that can be used to identify the epileptic region in patients evaluated as candidates for temporal lobe epilepsy surgery.
